• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酶Cε(PLCε)基因敲低通过抑制Yes相关蛋白(YAP)来阻止前列腺癌的丝氨酸/甘氨酸代谢和增殖。

PLCε knockdown prevents serine/glycine metabolism and proliferation of prostate cancer by suppressing YAP.

作者信息

Duan Li-Mei, Liu Jia-Yu, Yu Chao-Wen, Fan Jia-Xin, Li Ting, Yang Jin-Xiao, Zheng Yong-Bo, Liu Feng-Chun, He Zhen-Ting, Yuan Hong-Ling, Wu Xiao-Hou, Luo Chun-Li

机构信息

Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), School of Laboratory Medicine, Chongqing Medical University Chongqing 400016, China.

Department of Urology, The First Affiliated Hospital of Chongqing Medical University Chongqing 400016, China.

出版信息

Am J Cancer Res. 2020 Jan 1;10(1):196-210. eCollection 2020.

PMID:32064161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7017741/
Abstract

The metabolic reprogramming is an important basis for the development of many tumors, including prostate cancer (PCa). Metabolic changes in many amino acids consist of serine and glycine affect the biological behavior of them. Phospholipase C epsilon (PLCε) plays an important role as an oncogene. However, its role in regulating amino acid metabolism remains unclear. In this study, results found significantly positive correlation between PLCε and Yes-associated protein (YAP) in PCa tissues. LC-MS/MS and GC-MS results further displayed abnormally elevated levels of serine, glycine and its some downstream metabolites in the blood of PCa patients. Secondly, PLCε knockdown can inhibit serine/glycine producing and proliferation of PCa both in vivo and in vitro. Mechanistically, PLCε may affect the serine/glycine metabolism by regulating dephosphorylation and nuclear translocation of YAP. More interestingly, verteporfin (VP, a specific inhibitor of YAP) could effectively enhance the PLCε-depletion induced inhibition of serine/glycine secretion and growth. Overall, this research revealed the possibility of anomalous serine/glycine levels in the blood for the diagnosis of PCa, identified the important role of the PLCε/YAP axis in regulating serine/glycine metabolism, cell proliferation and tumor growth, and suggested the combination of VP with PLCε-depletion may provide a new idea for the treatment of PCa.

摘要

代谢重编程是包括前列腺癌(PCa)在内的许多肿瘤发生发展的重要基础。包括丝氨酸和甘氨酸在内的多种氨基酸的代谢变化会影响它们的生物学行为。磷脂酶Cε(PLCε)作为一种癌基因发挥着重要作用。然而,其在调节氨基酸代谢中的作用仍不清楚。在本研究中,结果发现PCa组织中PLCε与Yes相关蛋白(YAP)之间存在显著正相关。液相色谱-串联质谱(LC-MS/MS)和气相色谱-质谱(GC-MS)结果进一步显示,PCa患者血液中丝氨酸、甘氨酸及其一些下游代谢产物水平异常升高。其次,敲低PLCε在体内和体外均可抑制PCa的丝氨酸/甘氨酸生成和增殖。机制上,PLCε可能通过调节YAP的去磷酸化和核转位来影响丝氨酸/甘氨酸代谢。更有趣的是,维替泊芬(VP,YAP的特异性抑制剂)可有效增强PLCε缺失诱导的对丝氨酸/甘氨酸分泌和生长的抑制作用。总体而言,本研究揭示了血液中丝氨酸/甘氨酸水平异常用于PCa诊断的可能性,确定了PLCε/YAP轴在调节丝氨酸/甘氨酸代谢、细胞增殖和肿瘤生长中的重要作用,并表明VP与PLCε缺失联合应用可能为PCa治疗提供新思路。

相似文献

1
PLCε knockdown prevents serine/glycine metabolism and proliferation of prostate cancer by suppressing YAP.磷脂酶Cε(PLCε)基因敲低通过抑制Yes相关蛋白(YAP)来阻止前列腺癌的丝氨酸/甘氨酸代谢和增殖。
Am J Cancer Res. 2020 Jan 1;10(1):196-210. eCollection 2020.
2
PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.PLCε 通过上调 Twist1 调节前列腺癌细胞线粒体氧化代谢和迁移。
J Exp Clin Cancer Res. 2019 Aug 5;38(1):337. doi: 10.1186/s13046-019-1323-8.
3
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer.丝氨酸代谢通过USP7调节结肠癌中的YAP活性。
Front Cell Dev Biol. 2021 May 12;9:639111. doi: 10.3389/fcell.2021.639111. eCollection 2021.
4
Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.磷脂酶 Cε 通过靶向 AMP 激活的蛋白激酶(AMPK)/固醇调节元件结合蛋白 1(SREBP-1)信号通路调节前列腺癌脂代谢和增殖。
Med Sci Monit. 2020 Jul 22;26:e924328. doi: 10.12659/MSM.924328.
5
PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor.PLCε 敲低通过抑制 Notch 信号通路和雄激素受体的核转位抑制前列腺癌细胞增殖。
Cancer Lett. 2015 Jun 28;362(1):61-9. doi: 10.1016/j.canlet.2015.03.018. Epub 2015 Mar 18.
6
Knockdown of Phospholipase Cε (PLCε) Inhibits Cell Proliferation via Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN)/AKT Signaling Pathway in Human Prostate Cancer.敲低磷酸脂酶 Cε(PLCε)通过第 10 号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)/AKT 信号通路抑制人前列腺癌细胞增殖。
Med Sci Monit. 2018 Jan 13;24:254-263. doi: 10.12659/msm.908109.
7
A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.一个新的蛋白激酶 Cα/β/T 盒转录因子 3/上皮钙黏蛋白通路参与了 PLCε 调控的人膀胱癌细胞侵袭和迁移。
Cell Signal. 2014 Mar;26(3):580-93. doi: 10.1016/j.cellsig.2013.11.015. Epub 2013 Dec 6.
8
Phospholipase C epsilon mediates cytokine cascade induced by acute disruption of epidermal permeability barrier in mice.磷脂酶Cε介导小鼠表皮通透性屏障急性破坏诱导的细胞因子级联反应。
Biochem Biophys Rep. 2020 Dec 9;24:100869. doi: 10.1016/j.bbrep.2020.100869. eCollection 2020 Dec.
9
Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm.维替泊芬通过上调14-3-3σ将YAP隔离在细胞质中,从而抑制YAP功能。
Am J Cancer Res. 2015 Dec 15;6(1):27-37. eCollection 2016.
10
shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo.靶向 PLCε 的 shRNA 抑制膀胱癌在体和体外生长。
Urology. 2011 Aug;78(2):474.e7-11. doi: 10.1016/j.urology.2011.03.014. Epub 2011 Jun 25.

引用本文的文献

1
Mechanism and Therapeutic Progress of One-Carbon Metabolic Key Enzyme: Serine Hydroxymethyltransferase 2 in Cancer.一碳代谢关键酶:丝氨酸羟甲基转移酶2在癌症中的作用机制及治疗进展
Clin Med Insights Oncol. 2025 May 6;19:11795549251331755. doi: 10.1177/11795549251331755. eCollection 2025.
2
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank.基于核磁共振的代谢组学与胰腺癌风险:英国生物银行的前瞻性分析
J Gastroenterol. 2025 Jun;60(6):794-807. doi: 10.1007/s00535-025-02237-9. Epub 2025 Mar 12.
3
HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1.HuR 通过转录后调控 BCAT1 改变 ERK5 的激活促进去势抵抗性前列腺癌的进展。
J Transl Med. 2024 Feb 18;22(1):178. doi: 10.1186/s12967-024-04970-w.
4
Potential Roles of YAP/TAZ Mechanotransduction in Spaceflight-Induced Liver Dysfunction.YAP/TAZ 机械转导在航天飞行诱导的肝功能障碍中的潜在作用。
Int J Mol Sci. 2023 Jan 22;24(3):2197. doi: 10.3390/ijms24032197.
5
Extracellular-matrix mechanics regulate cellular metabolism: A ninja warrior behind mechano-chemo signaling crosstalk.细胞外基质力学调节细胞代谢:机械化学信号串扰背后的“忍者战士”
Rev Endocr Metab Disord. 2023 Apr;24(2):207-220. doi: 10.1007/s11154-022-09768-z. Epub 2022 Nov 17.
6
Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer.缺氧与乳腺癌肿瘤微环境细胞外基质的相互作用
Genes (Basel). 2022 Sep 3;13(9):1585. doi: 10.3390/genes13091585.
7
Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.mTOR 通路和氨基酸代谢在前列腺癌中的双重作用。
Cell Oncol (Dordr). 2022 Oct;45(5):831-859. doi: 10.1007/s13402-022-00706-4. Epub 2022 Aug 29.
8
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer.丝氨酸代谢通过USP7调节结肠癌中的YAP活性。
Front Cell Dev Biol. 2021 May 12;9:639111. doi: 10.3389/fcell.2021.639111. eCollection 2021.
9
Extracellular Matrix Stiffness: New Areas Affecting Cell Metabolism.细胞外基质硬度:影响细胞代谢的新领域
Front Oncol. 2021 Feb 24;11:631991. doi: 10.3389/fonc.2021.631991. eCollection 2021.
10
Novel Metabolic Signatures of Prostate Cancer Revealed by H-NMR Metabolomics of Urine.尿液的氢核磁共振代谢组学揭示前列腺癌的新型代谢特征
Diagnostics (Basel). 2021 Jan 20;11(2):149. doi: 10.3390/diagnostics11020149.

本文引用的文献

1
PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.PLCε 通过上调 Twist1 调节前列腺癌细胞线粒体氧化代谢和迁移。
J Exp Clin Cancer Res. 2019 Aug 5;38(1):337. doi: 10.1186/s13046-019-1323-8.
2
Simvastatin delays castration‑resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin‑1.辛伐他汀通过调节窖蛋白-1 的表达延缓去势抵抗性前列腺癌转移和雄激素受体拮抗剂耐药。
Int J Oncol. 2019 Jun;54(6):2054-2068. doi: 10.3892/ijo.2019.4774. Epub 2019 Apr 5.
3
Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine.氨基酸代谢的前列腺癌特异性特征:迈向精准医学的范例。
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):248-258. doi: 10.1016/j.bbcan.2019.01.001. Epub 2019 Jan 29.
4
PLCε knockdown overcomes drug resistance to androgen receptor antagonist in castration-resistant prostate cancer by suppressing the wnt3a/β-catenin pathway.通过抑制Wnt3a/β-连环蛋白通路,PLCε基因敲低克服了去势抵抗性前列腺癌对雄激素受体拮抗剂的耐药性。
J Cell Physiol. 2019 Sep;234(9):15472-15486. doi: 10.1002/jcp.28195. Epub 2019 Jan 26.
5
Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.表观上调的癌蛋白 PLCE1 通过激活 PI-PLCε-NF-κB 信号通路和 VEGF-C/Bcl-2 表达,驱动食管癌血管生成和增殖。
Mol Cancer. 2019 Jan 4;18(1):1. doi: 10.1186/s12943-018-0930-x.
6
Interplay between YAP/TAZ and Metabolism.YAP/TAZ 与代谢之间的相互作用。
Cell Metab. 2018 Aug 7;28(2):196-206. doi: 10.1016/j.cmet.2018.07.010.
7
GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.GPER/Hippo-YAP 信号参与双酚 S 诱导的三阴性乳腺癌(TNBC)细胞迁移。
J Hazard Mater. 2018 Aug 5;355:1-9. doi: 10.1016/j.jhazmat.2018.05.013. Epub 2018 May 8.
8
[Verteporfin inhibits proliferation, invasion and migration of MDA-MB-231 human breast cancer cells by down-regulating the expression of Yes-associated protein].[维替泊芬通过下调Yes相关蛋白的表达抑制MDA-MB-231人乳腺癌细胞的增殖、侵袭和迁移]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Sep;33(9):1223-1227.
9
Dual roles of yes-associated protein (YAP) in colorectal cancer.Yes相关蛋白(YAP)在结直肠癌中的双重作用。
Oncotarget. 2017 Aug 11;8(43):75727-75741. doi: 10.18632/oncotarget.20155. eCollection 2017 Sep 26.
10
YAP/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression.YAP/TAZ 介导的丝氨酸代谢和甲基化调控的激活对于 LKB1 缺失型乳腺癌的进展至关重要。
Biosci Rep. 2017 Oct 24;37(5). doi: 10.1042/BSR20171072. Print 2017 Oct 31.